Seeing Is Believing

Currently out of the existing stock ratings of Lance Wilkes, 40 are a BUY (68.97%), 18 are a HOLD (31.03%).
Analyst Lance Wilkes, currently employed at BERNSTEIN, carries an average stock price target met ratio of 57.17% that have a potential upside of 28.64% achieved within 352 days.
Lance Wilkes’s has documented 122 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CVS, CVS Health Corp at 12-Dec-2025.
Analyst best performing recommendations are on AGL (AGILON HEALTH).
The best stock recommendation documented was for CNC (CENTENE CORP) at 9/5/2025. The price target of $36 was fulfilled within 27 days with a profit of $7.02 (24.22%) receiving and performance score of 8.97.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 02-Jul-2021
$533
$50.42 (10.45%)
$617
3 years 6 months 16 days ago
(22-Jun-2022)
2/4 (50%)
$67.25 (14.44%)
125
Buy
Since 09-Jul-2021
$550
$67.42 (13.97%)
$430
3 years 6 months 22 days ago
(16-Jun-2022)
1/2 (50%)
$95.24 (20.94%)
108
Buy
Since 27-Apr-2017
$596
$113.42 (23.50%)
$574
3 years 7 months 11 days ago
(27-May-2022)
3/5 (60%)
$76.79 (14.79%)
741
Buy
$580
$97.42 (20.19%)
$586
3 years 7 months 13 days ago
(25-May-2022)
4/6 (66.67%)
$67.58 (15.14%)
149
Buy
Since 21-Dec-2021
$545
$62.42 (12.93%)
3 years 8 months 3 days ago
(04-May-2022)
6/7 (85.71%)
$36.02 (7.08%)
40
Which stock is Lance Wilkes is most bullish on?
Which stock is Lance Wilkes is most reserved on?
What Year was the first public recommendation made by Lance Wilkes?